Trials / Completed
CompletedNCT03942250
Uses of Irradiated Human Amniotic Membrane in the Treatment of Dystrophic Epidermolysis Bullosa Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Egyptian Atomic Energy Authority · Other Government
- Sex
- All
- Age
- 12 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the effect of human amniotic membrane as a weekly dressing on chronic wounds in Epidermolysis Bullosa (EB) patients.
Detailed description
Dried human amniotic membrane dressing were obtained from National center for radiation research and technology, Egypt (NCRRT), under commercial name REGE pro.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | REGE pro dressing | REGE pro is a dressing of dried human amniotic membrane sterilized by gamma radiation |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2017-12-01
- Completion
- 2019-02-01
- First posted
- 2019-05-08
- Last updated
- 2023-09-21
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03942250. Inclusion in this directory is not an endorsement.